체외막산소공급장치(ECMO) 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of extracorporeal membrane oxygenation (ECMO) machine Market

The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 552.8 million in 2025 and is projected to grow to USD 574.8 million in 2026. The market is further expected to reach USD 790.05 million by 2034, exhibiting a CAGR of 4.06% during the forecast period (2026-2034).

North America dominated the global ECMO machine market with a 49.36% market share in 2025, driven by the high prevalence of cardiovascular diseases, rising number of surgical procedures, and strong presence of leading market players.

ECMO is an advanced life-support system used to oxygenate blood outside the body and provide circulatory support. It operates primarily in two modes: Veno-Arterial (VA) and Veno-Venous (VV). The technology is widely used in patients suffering from respiratory failure, acute respiratory distress syndrome (ARDS), pulmonary embolism, cardiogenic shock, open-heart surgery complications, and severe COVID-19 cases.

Market Drivers

Rising Prevalence of Cardiovascular and Respiratory Diseases

The growing burden of cardiovascular diseases (CVDs) and respiratory disorders is a major factor driving ECMO machine demand. Globally, cardiovascular diseases account for approximately 18.6 million deaths annually. Additionally, ARDS, chronic obstructive pulmonary disease (COPD), and respiratory failure cases continue to rise, increasing the need for advanced life-support systems.

In the U.S., around 190,000 ARDS cases are reported annually. Furthermore, nearly 4,600 lung transplant procedures are performed globally each year, with North America and Europe accounting for nearly 80% of the total. These factors significantly contribute to the expansion of the ECMO machine market.

Technological Advancements

Continuous innovations such as miniaturized oxygenators, advanced rotary pumps, dual-lumen cannula, improved circuit coatings, and magnetic levitation centrifugal pumps have enhanced patient outcomes. Modern ECMO systems offer rapid priming, lower blood flow resistance, reduced plasma leakage, and minimized complications, encouraging higher adoption across hospitals and critical care units.

COVID-19 Impact

The COVID-19 pandemic positively impacted the ECMO machine market due to increased demand for respiratory and circulatory support. Hospitals expanded ECMO capacity to treat critically ill COVID-19 patients. Major players reported revenue growth during the pandemic due to increased demand for ECMO systems.

The surge in usage during 2020 and 2021 strengthened the adoption of ECMO machines globally and established them as critical infrastructure in intensive care units.

Market Restraints

Despite strong demand, the high cost of ECMO systems limits adoption in developing economies. In the U.S., an ECMO system costs between USD 152,000 and USD 170,000, while in India, prices range from USD 35,000 to USD 48,000. The total procedural cost, including consumables and skilled personnel, further increases affordability challenges, especially in low-income healthcare systems.

Segmentation Analysis

By Type

The market is segmented into Veno-Arterial (VA) and Veno-Venous (VV) systems.

• The Veno-Arterial segment held the largest share of 59.01% in 2025, owing to its extensive use in cardiac support and congenital heart defect cases.
• The Veno-Venous segment is expected to grow steadily due to increasing respiratory failure cases and its widespread use during COVID-19.

By Application

The market is segmented into adult, pediatric, and neonatal.

• The adult segment dominated with a 76.46% share in 2026, driven by high incidence of cardiac and respiratory disorders in adults.
• The pediatric segment is expected to grow steadily due to rising pneumonia and congenital heart disease cases.
• The neonatal segment shows moderate growth due to procedural complications and risk factors.

Regional Insights

North America

North America led the market in 2025, supported by advanced healthcare infrastructure and strong manufacturer presence. The U.S. continues to drive regional growth due to high cardiovascular mortality rates.

Europe

Europe is expected to grow at a substantial rate through 2034 due to favorable reimbursement policies and increased R&D investments.

Asia Pacific

Asia Pacific is projected to witness the highest CAGR during 2026-2034, supported by expanding ECMO centers, large patient pool, and growing healthcare investments in China, Japan, and India.

Latin America & Middle East & Africa

These regions are expected to grow at a moderate pace due to improving healthcare infrastructure and increasing adoption of advanced medical technologies.

Competitive Landscape

The ECMO machine market is consolidated, with major players including Getinge AB, Terumo Corporation, Medtronic plc, LivaNova PLC, Xenios AG, EUROSETS, ABIOMED, NIPRO, and Spectrum Medical.

Companies focus on product innovation, acquisitions, and regulatory approvals to strengthen their market position. Strategic developments and expansion of product portfolios are key competitive strategies.

Conclusion

The global ECMO machine market is set to grow steadily from USD 552.8 million in 2025 to USD 574.8 million in 2026, reaching USD 790.05 million by 2034, at a CAGR of 4.06%. Growth is primarily driven by the rising prevalence of cardiovascular and respiratory diseases, increasing adoption of advanced life-support technologies, and expanding ECMO centers worldwide.

North America remains the dominant region with a 49.36% share in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period. Although high system costs pose a challenge, continuous technological advancements and growing healthcare investments are expected to sustain long-term market expansion through 2034.

Segmentation By Type, Application, and Region

By Type * Veno-Arterial

• Veno-Venous

By Application

Adult

• Pediatric
• Neonatal

By Region * North America (By Type, By Application, By Country)

• U.S.
• Canada
• Europe (By Type, By Application, By Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, By Application, By Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Application, By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa (By Type, By Application, By Country/Sub-region)
  • South Africa
  • GCC
  • Rest of Middle East and Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Heart and Lung Transplantations, By Key Countries, 2025
• 4.2. New Product Launches
• 4.3. Key Industry Developments - Key Mergers, Acquisitions and Partnerships
• 4.4. Impact of COVID-19 on the Extracorporeal Membrane Oxygenation (ECMO) Machine Market

5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. VA (Veno-Arterial) ECMO Machine
  • 5.1.2. VV (Veno-Venous) ECMO Machine
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Adult
  • 5.2.2. Pediatric
  • 5.2.3. Neonatal
• 5.3. Market Analysis, Insights and Forecast - By Geography
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. VA (Veno-Arterial) ECMO Machine
  • 6.1.2. VV (Veno-Venous) ECMO Machine
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Adult
  • 6.2.2. Pediatric
  • 6.2.3. Neonatal
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. VA (Veno-Arterial) ECMO Machine
  • 7.1.2. VV (Veno-Venous) ECMO Machine
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Adult
  • 7.2.2. Pediatric
  • 7.2.3. Neonatal
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Scandinavia
  • 7.3.7. Rest of Europe

8. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. VA (Veno-Arterial) ECMO Machine
  • 8.1.2. VV (Veno-Venous) ECMO Machine
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Adult
  • 8.2.2. Pediatric
  • 8.2.3. Neonatal
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. India
  • 8.3.4. South Korea
  • 8.3.5. Australia
  • 8.3.6. Southeast Asia
  • 8.3.7. Rest of Asia Pacific

9. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. VA (Veno-Arterial) ECMO Machine
  • 9.1.2. VV (Veno-Venous) ECMO Machine
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Adult
  • 9.2.2. Pediatric
  • 9.2.3. Neonatal
• 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America

10. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. VA (Veno-Arterial) ECMO Machine
  • 10.1.2. VV (Veno-Venous) ECMO Machine
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Adult
  • 10.2.2. Pediatric
  • 10.2.3. Neonatal
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
  • 11.2.1. Getinge AB
    • 11.2.1.1. Overview,
    • 11.2.1.2. Products,
    • 11.2.1.3. SWOT Analysis,
    • 11.2.1.4. Recent Developments,
    • 11.2.1.5. Strategies,
    • 11.2.1.6. financials (based on availability)
  • 11.2.2. LivaNova PLC
    • 11.2.2.1. Overview,
    • 11.2.2.2. Products,
    • 11.2.2.3. SWOT Analysis,
    • 11.2.2.4. Recent Developments,
    • 11.2.2.5. Strategies,
    • 11.2.2.6. financials (based on availability)
  • 11.2.3. Xenios AG (Fresenius Medical Care)
    • 11.2.3.1. Overview,
    • 11.2.3.2. Products,
    • 11.2.3.3. SWOT Analysis,
    • 11.2.3.4. Recent Developments,
    • 11.2.3.5. Strategies,
    • 11.2.3.6. financials (based on availability)
  • 11.2.4. EUROSETS
    • 11.2.4.1. Overview,
    • 11.2.4.2. Products,
    • 11.2.4.3. SWOT Analysis,
    • 11.2.4.4. Recent Developments,
    • 11.2.4.5. Strategies,
    • 11.2.4.6. financials (based on availability)
  • 11.2.5. ABIOMED
    • 11.2.5.1. Overview,
    • 11.2.5.2. Products,
    • 11.2.5.3. SWOT Analysis,
    • 11.2.5.4. Recent Developments,
    • 11.2.5.5. Strategies,
    • 11.2.5.6. financials (based on availability)
  • 11.2.6. Medtronic
    • 11.2.6.1. Overview,
    • 11.2.6.2. Products,
    • 11.2.6.3. SWOT Analysis,
    • 11.2.6.4. Recent Developments,
    • 11.2.6.5. Strategies,
    • 11.2.6.6. financials (based on availability)
  • 11.2.7. NIPRO
    • 11.2.7.1. Overview,
    • 11.2.7.2. Products,
    • 11.2.7.3. SWOT Analysis,
    • 11.2.7.4. Recent Developments,
    • 11.2.7.5. Strategies,
    • 11.2.7.6. financials (based on availability)
  • 11.2.8. Spectrum Medical
    • 11.2.8.1. Overview,
    • 11.2.8.2. Products,
    • 11.2.8.3. SWOT Analysis,
    • 11.2.8.4. Recent Developments,
    • 11.2.8.5. Strategies,
    • 11.2.8.6. financials (based on availability)
  • 11.2.9. Terumo Corporation
    • 11.2.9.1. Overview,
    • 11.2.9.2. Products,
    • 11.2.9.3. SWOT Analysis,
    • 11.2.9.4. Recent Developments,
    • 11.2.9.5. Strategies,
    • 11.2.9.6. financials (based on availability)